Jasper Therapeutics, Inc. — Director's Dealing 2021

Oct 1, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Jasper Therapeutics, Inc. (JSPR)
CIK: 0001788028
Period of Report: 2021-09-24

Reporting Person: Shizuru Judith Anne (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Voting Common Stock	1129512	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.71	2030-05-31	Common Stock (146170)		Direct

Footnotes

F1: Includes 305,909 shares of restricted stock that are subject to vesting, of which 1/26th shall vest on October 20, 2021 and each month thereafter through and including November 20, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date.